Should these opioids be schedule 1 drugs?
More than 100 researchers, scientists and public health professionals want fentanyl-related substances to no longer be Schedule I drugs — saying a different classification has the potential to unlock research on those drugs to treat opioid addiction or other mental health conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns Hopkins University, explains a new study on using buprenorphine in Medicare patients.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
More than 100 researchers, scientists and public health professionals want fentanyl-related substances to no longer be Schedule I drugs — saying a different classification has the potential to unlock research on those drugs to treat opioid addiction or other mental health conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns Hopkins University, explains a new study on using buprenorphine in Medicare patients.
Learn more about your ad choices. Visit megaphone.fm/adchoices